Lightning Round: Alexion Pharmaceuticals, Barclays, Calumet Specialty and More
American Capital Agency : Jim Cramer said he's sticking with this stock.
Alexion Pharmaceuticals : This is a very speculative stock, Cramer said. While he doesn't think it should be sold, he warned it could come down in price.
Barclays : Cramer prefers domestic banks right now.
Sarepta Therapeutics : This is a "highly speculative stock," Cramer said, adding he'd pull the trigger should it hit the $20s.
Calumet Specialty : Go with Linn Energy instead, Cramer said.
@MadMoneyOnCNBC on Twitter
"Mad Money" on Facebook
Call Cramer: 1-800-743-CNBC
Questions for Cramer? madmoney@cnbc.com
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com


